<DOC>
	<DOCNO>NCT01633398</DOCNO>
	<brief_summary>The ASIAN HF Registry first prospective multinational Asian registry patient symptomatic HF ( stage C ) 11 include HFrEF ( ejection fraction &lt; 40 % ) 3 HFpEF ( ejection fraction ≥50 % ) , broad purpose determine mortality ( incidence ) burden HF Asian patient , specifically define burden risk factor Sudden Cardiac Deaths ( SCD ) , well sociocultural barrier preventive device therapy . The study aim study genetic variant associate HFrEF versus HFpEF large Asian cohort . This propose registry expect advance fundamental understanding burden predictor preventable death among Asian patient HF . The knowledge gain critical guiding resource allocation plan preventive strategy address unmet grow clinical need patient cardiovascular disease Asia .</brief_summary>
	<brief_title>ASIAN HF Registry , A Prospective Observational Study</brief_title>
	<detailed_description>Heart failure ( HF ) major public health problem worldwide . As final common pathway myriad heart disease , HF burden increase increase prevalence cardiovascular disease community , patient survive acute cardiac condition ( heart attack ) progress chronic HF . Further , HF debilitate deadly condition high rehospitalization rate dismal survival rate comparable cancer . In Singapore alone , age-adjusted HF admission rate rise ~40 % last decade,1 make HF common cardiac cause hospitalization ( represent ~24 % cardiac admission ) , 5-year survival rate patient HF 32 % . These alarm statistic reflect global shift cardiovascular disease burden develop country Asia . In fact , World Health Organization project large increase cardiovascular disease worldwide occur Asia , due rapidly increase rate smoke , obesity , dyslipidemia diabetes among Asians . Thus burden HF expect reach epidemic proportion Asia . Yet sharp contrast wealth data regard HF Western nation , epidemiologic data scarce Asian patient HF . The study involve 46 top medical center across 11 Asian region ( Korea , Thailand , Indonesia , Philippines , India , Japan , Malaysia , Hong Kong , China , Taiwan Singapore ) . Site selection target mix center cover broad spectrum medical , cardiology HF specialty unit regularly admit patient acute HF follow outpatient chronic HF , constitute novel network Asian center cardiovascular expertise . Data collection include demographic variable , clinical symptom , functional status , date HF diagnosis prior cardiovascular investigation , clinical risk factor , lifestyle factor , socioeconomic status , survey cultural belief , health practice attitudes towards device therapy . Center-level characteristic ( caseload , referral pattern , specialization , infrastructure ) also obtain . Patients undergo standard 12-lead electrocardiography transthoracic echocardiography baseline , follow 3 year outcomes death hospitalization . Each outcome event cause adjudicate central committee use pre-specified criterion .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Adults ( &gt; 18 year ) 2 . Symptomatic HF ( Stage C HF regardless functional status ) . Patients current diagnosis symptomatic HF within 6 month episode decompensated heart failure* , either : ( ) result hospital admission ( primary diagnosis ) b ) treat outpatient clinic 3 . Left ventricular ejection fraction &lt; 40 % ( HFrEF ) leave ventricular ejection fraction ≥50 % ( HFpEF ) baseline echocardiography 4 . Available followup 3 year 1 . Severe valve disease primary cause HF 2 . For HFpEF population : documented history reduce ejection fraction ( &lt; 50 % ) time prior recruitment , In word , patient current HFpEF previously HFrEF exclude . 3 . Life threaten comorbidity life expectancy &lt; 1 year 4 . Unable unwilling give consent 5 . Concurrent participation clinical therapeutic trial require patient consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>HF</keyword>
</DOC>